Sadra Medical raises $30M for aortic valve replacement
Sadra Medical, which is developing a procedure to replace the aortic valve (for the less medically-savvy, that’s part of your heart), has raised $30 million in a third round of funding. The Campbell, Calif., company dubs its procedure “percutaneous aortic valve replacement,” and it involves placing the prosthetic valve in a patient’s heart by threading a catheter through their arteries. The round was led by Accuitive Medical Ventures, with participation from previous investors Boston Scientific, Finister, Firstmark Capital, Oakwood, ONSET Ventures, and SV Lifescience.
Sadra has now raised a total of $58 million, according to numbers from VentureWire.
Next Story: Twitter enterprises take off but can they turn a profit?
Previous Story: Amazon funds online cooking encyclopedia Foodista
About the Author, Anthony Ha
Anthony is a senior editor at VentureBeat, as well as its reporter on media, advertising, and social networks. Before joining the site in 2008, Anthony worked at the Hollister Free Lance, where he won awards from the California Newspaper Publishers Association for breaking news coverage and writing. He attended Stanford University and now lives in San Francisco. Reach him at anthony@venturebeat.com. (All story pitches should also be sent to tips@venturebeat.com) You can also follow Anthony on Twitter.
